Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia:: A fluorescent in situ hybridization study

被引:94
作者
Brunelli, M
Eble, JN
Zhang, SB
Martignoni, G
Cheng, L
机构
[1] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA
[2] Univ Verona, Dipartimento Patol, I-37100 Verona, Italy
[3] Univ Sassari, I-07100 Sassari, Italy
关键词
fluorescence in situ hybridization; papillary renal adenoma; papillary renal carcinoma; kidney neoplasia;
D O I
10.1097/01.MP.0000090924.90762.94
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
it has been suggested that gains of chromosomes 7 and 17 and loss of Y occur in renal papillary adenoma and that progression to papillary renal cell carcinoma is marked by gains of additional chromosomes, most frequently 12, 16, and 20. Previous studies have included very few lesions of <5 mm in diameter, a requirement of the present definition of papillary adenoma. Ten papillary adenomas (ranging from I to 5 nun in diameter) from autopsy material and 10 surgically resected papillary renal cell carcinomas were studied with fluorescence in situ hybridization in paraffin sections using centromeric probes for chromosomes 7, 12, 16, 17, 20, and Y diluted 1: 100 with tDen-Hybl buffer. The signals in 50 to 150 nuclei were counted in each tumor. Controls for all the probes were normal renal tissues from the same patients. Three or more signals per nucleus were frequently observed in papillary adenomas: chromosome 7 (range, 10 to 50%; greater than or equal to30% in 9 of 10), 17 (range, 10 to 47%; greater than or equal to30% in 7),16 (range, I to 63%; greater than or equal to10% in 5),12 (range, 0 to 32%; greater than or equal to10% in 4), and 20 (range, 5 to 49%; greater than or equal to10% in 5). Loss of the Y chromosome was observed in 80 to 90% of nuclei in 9 adenomas from males. Three or more signals were frequent in papillary renal cell carcinomas: chromosome 7 (range, 32 to 63%; greater than or equal to30% in 10 of 10), 17 (range, 28 to 61%; greater than or equal to30% in 7), 16 (range, 0 to 45%; greater than or equal to10% in 6), 12 (range, 1 to 37, greater than or equal to10% in 5),20 (range, 2 to 44%; greater than or equal to10% in 4). No signal for Y was observed in 12 to 88% ( greater than or equal to81% in 6) of nuclei in 7 carcinomas from males. Statistical analysis showed no difference between adenomas and carcinomas. Gains of chromosomes 7, 17, 16, 12, and 20 and loss of the Y chromosome occur early in the evolution of papillary renal cell neoplasia in tumors that are only a few millimeters in diameter. Progressive gains of these chromosomes do not appear to correlate with the transition from adenoma to carcinoma.
引用
收藏
页码:1053 / 1059
页数:7
相关论文
共 27 条
[1]   Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization [J].
Bentz, M ;
Bergerheim, USR ;
Li, C ;
Joos, S ;
Werner, CA ;
Baudis, M ;
Gnarra, J ;
Merino, MJ ;
Zbar, B ;
Linehan, WM ;
Lichter, P .
CYTOGENETICS AND CELL GENETICS, 1996, 75 (01) :17-21
[2]   Papillary renal cell carcinoma - Quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy [J].
Corless, CL ;
Aburatani, H ;
Fletcher, JA ;
Housman, DE ;
Amin, MB ;
Weinberg, DS .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1996, 5 (01) :53-64
[3]  
DALCIN P, 1989, AM J CLIN PATHOL, V92, P408
[4]  
Delahunt B, 1997, MODERN PATHOL, V10, P537
[5]  
EBLE JN, 1991, MODERN PATHOL, V4, pA45
[6]   PAPILLARY RENAL-CELL CARCINOMA - CLINICAL IMPLICATION OF DNA CONTENT-ANALYSIS [J].
ELNAGGAR, AK ;
RO, JY ;
ENSIGN, LG .
HUMAN PATHOLOGY, 1993, 24 (03) :316-321
[7]  
FARNSWORTH WV, 1994, J UROL PATHOL, V2, P65
[8]   Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumours [J].
Fischer, J ;
Palmedo, G ;
von Knobloch, R ;
Bugert, P ;
Prayer-Galetti, T ;
Pagano, F ;
Kovacs, G .
ONCOGENE, 1998, 17 (06) :733-739
[9]   Numerical chromosomal aberrations in papillary renal cortical tumors - Relationship with histopathologic features [J].
Henke, RP ;
Erbersdobler, A .
VIRCHOWS ARCHIV, 2002, 440 (06) :604-609
[10]   DETECTION OF GENOMIC CHANGES IN CANCER BY IN-SITU HYBRIDIZATION [J].
HOPMAN, AHN ;
VOORTER, CEM ;
RAMAEKERS, FCS .
MOLECULAR BIOLOGY REPORTS, 1994, 19 (01) :31-44